Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma

Published:2017-01 Issue:1 Volume:25 Page:39-43
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Massari Francesco,Ciccarese Chiara,Bria Emilio,Porta Camillo,La Russa Francesca,Knuutila Sakari,Artibani Walter,Porcaro Antonio Benito,Bimbatti Davide,Modena Alessandra,Sava Teodoro,Tortora Giampaolo,Cheng Liang,Eccher Albino,Cima Luca,Pedron Serena,Ghimenton Claudio,Martignoni Guido,Brunelli Matteo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference23 articles.

1. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma;de Oliveira;Urol Oncol,2014

2. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma;Brunelli;Mod Pathol,2008

3. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma;Klatte;J Clin Oncol,2009

4. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma;La Rochelle;Cancer,2010

5. Genetic and functional studies implicate HIF1alpha as a 14q kidney cancer suppressor gene;Shen;Cancer Discov,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort;Nature Communications;2023-12-16

2. Association between copy-number alteration of +20q, −14q and −18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma;Cancer Cell International;2020-10-06

3. Chromosome Abnormalities: New Insights into Their Clinical Significance in Cancer;Molecular Therapy - Oncolytics;2020-06

4. Long non-coding RNA TCL6 enhances preferential toxicity of paclitaxel to renal cell carcinoma cells;Journal of Cancer;2020

5. A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss;Molecular Diagnosis & Therapy;2019-07-22